Central Nervous System Imaging in Rheumatic Diseases

被引:0
|
作者
Badihian, Shervin [1 ]
Kiczek, Matthew P. [2 ]
Hajj-Ali, Rula A. [3 ]
机构
[1] Cleveland Clin, Neurol Inst, Dept Neurol, 9500 Euclid Ave, Cleveland, OH 44195 USA
[2] Cleveland Clin, Dept Radiol & Imaging, 9500 Euclid Ave, Cleveland, OH 44195 USA
[3] Cleveland Clin, Lerner Coll Med, Ctr Vasculitis Care & Res, Dept Rheumat & Immunol Dis, 9500 Euclid Ave, Cleveland, OH 44195 USA
关键词
Rheumatic diseases; Central nervous system; Imaging; Neuroimaging; Systemic lupus erythematosus; Vasculitis; GIANT-CELL ARTERITIS; CLINICAL CHARACTERISTICS; NEUROPSYCHIATRIC MANIFESTATIONS; LUPUS-ERYTHEMATOSUS; PRIMARY ANGIITIS; BEHCETS-DISEASE; INVOLVEMENT; VASCULITIS; MRI; DIAGNOSIS;
D O I
10.1016/j.rdc.2024.07.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A summary of CNS complications seen in rheumatic disorders is presented in Table 1. When evaluating a patient with a rheumatic disease, it is important to look for neurologic symptoms and obtain further imaging when needed. Early diagnosis of these conditions leads to earlier treatment and therefore decreased disability. When there are concerns for cerebrovascular disease, CT scan, MRI, and vessel imaging are part of the diagnostic workup. CT scan is more sensitive in the detection of hemorrhage, while MRI with DWI sequences is the modality of choice for ischemic infarcts. Moreover, other conditions such as CVST and PRES may be seen on MRI. Vessel imaging is done to assess the integrity of CNS vessels and evidence of stenoses, occlusion, aneurysm, dissection, or vasculitis. CTA, MRA, and DSA are the angiographic studies routinely used in practice. CTV and MRV are the imaging modalities of choice for CVST. When the presentation is concerning for a vasculitic process, high- resolution MRI with vessel wall imaging may be of value. Lastly, Doppler ultrasound is used for large-vessel vasculitides. For evaluation of parenchymal diseases such as demyelinating conditions and lesions and optic neuritis, brain MRI with gadolinium contrast is the modality of choice. MRI of the cervical, thoracic, and lumbar spine with gadolinium contrast is used for workup of myelitis. MRI of orbit is more sensitive to show changes in the optic nerve. Similarly, for assessment of pituitary involvement, brain MRI is a diagnostic modality. In diseases such as RA that lead to spinal instability and compression myelopathy, spinal CT scan is the modality of choice to visualize bony changes. Spinal MRI may also be used to assess the extent of myelopathy and soft tissue abnormalities. For headache disorders, imaging is usually not necessary unless the rheumatic condition is associated with hypercoagulable state or higher chances of secondary headache disorders such as CVST or IIH. In these cases, CTV or MRV would be needed to rule out these secondary causes. For aseptic meningitis, the clinical workup is usually focused on CSF studies. However, MRI brain with gadolinium contrast may show meningeal enhancement. To assess meningeal diseases such as pachymeningitis or leptomeningitis, MRI brain with IV contrast is the modality of choice. Seizures, as a common presentation of rheumatic diseases, may be lesional or nonlesional. Given the probability of lesional causes (such as CVST and PRES), for new- onset seizures, obtaining neuroimaging is necessary. Similarly, movement disorders such as chorea may be caused in the setting of CNS lesions among these patients and need further workup with neuroimaging.
引用
收藏
页码:559 / 579
页数:21
相关论文
共 50 条
  • [41] Vascular Imaging Outcomes of Childhood Primary Angiitis of the Central Nervous System
    Elbers, Jorina
    Armstrong, Derek
    Yau, Ivanna
    Benseler, Susanne
    PEDIATRIC NEUROLOGY, 2016, 63 : 53 - 59
  • [42] Ergothioneine and central nervous system diseases
    Noritaka Nakamichi
    Sota Tsuzuku
    Fumiya Shibagaki
    Neurochemical Research, 2022, 47 : 2513 - 2521
  • [43] Parasitic diseases of the central nervous system
    Chacko, Geeta
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2010, 27 (03) : 167 - 185
  • [44] Ergothioneine and central nervous system diseases
    Nakamichi, Noritaka
    Tsuzuku, Sota
    Shibagaki, Fumiya
    NEUROCHEMICAL RESEARCH, 2022, 47 (09) : 2513 - 2521
  • [45] Inflammation and the Central Nervous System in Inflammatory Rheumatic Disease
    Kaplan, Chelsea
    Minc, Alexa
    Basu, Neil
    Schrepf, Andrew
    CURRENT RHEUMATOLOGY REPORTS, 2019, 21 (12)
  • [46] Central Nervous System Vasculitis: Still More Questions than Answers
    Alba, Marco A.
    Espigol-Frigole, Georgina
    Prieto-Gonzalez, Sergio
    Tavera-Bahillo, Itziar
    Garcia-Martinez, Ana
    Butjosa, Montserrat
    Hernandez-Rodriguez, Jose
    Cid, Maria C.
    CURRENT NEUROPHARMACOLOGY, 2011, 9 (03) : 437 - 448
  • [47] Novel imaging and related techniques for studies of diseases of the central nervous system: a review
    Dai, Zhenfeng
    Sun, Yi
    Zhao, Xin
    Pu, Xiaoping
    CELL AND TISSUE RESEARCH, 2020, 380 (03) : 415 - 424
  • [48] Novel imaging and related techniques for studies of diseases of the central nervous system: a review
    Zhenfeng Dai
    Yi Sun
    Xin Zhao
    Xiaoping Pu
    Cell and Tissue Research, 2020, 380 : 415 - 424
  • [49] Advances in Primary Angiitis of the Central Nervous System
    Lucke, Michael
    Hajj-Ali, Rula A.
    CURRENT CARDIOLOGY REPORTS, 2014, 16 (10) : 1 - 7
  • [50] Routine MR Imaging Protocol and Standardization in Central Nervous System Demyelinating Diseases
    Traboulsee, Anthony
    Li, David K. B.
    NEUROIMAGING CLINICS OF NORTH AMERICA, 2024, 34 (03) : 317 - 334